ANNUAL REPORT THREADBARE

Size: px
Start display at page:

Download "ANNUAL REPORT THREADBARE"

Transcription

1 GODREJ CONSUMER PRODUCTS FY13 Our analysis of Godrej Consumer Products' (GCPL) FY13 annual report provides answers on why the company's consolidated tax rate fell to 17% in FY13 from 23% in FY12 and how these tax rates are likely to pan out, going forward. We also note that GCPL amortizes expenses of ~INR776m (8.3% of FY13 PBT) directly through reserves, partly on account of amortization of brands (5.9% of PBT) and partly as premium on redemption of debentures (2.4% of PBT). ART #1: Accounting/Auditing issues Consolidated tax rate declined to 17% in FY13 from 23% in FY12, due to subsidiaries (derived) tax rate going down to 15% in FY13 (FY12: 33%). Subsidiaries tax rate declined due to tax savings on royalty income on products sold in Indonesia increasing from 1.8% in FY12 to 7.9% in FY13. Indovest Capital, subsidiary in Labuan, Malaysia royalty transaction structuring Tax Rate: 0% Tax Rate: 30% Indovest Capital, Labuan, Malaysia FY13 Turnover: INR1.8b, PBT/PAT: INR1.7b Trademarks for brands sold in Indonesia Royalty Income PT Intrasari Raya, Witholding PT Megasari Makmur tax of 10% Indonesia Also, Nigerian and Mozambican subsidiaries enjoy corporate tax holidays and so does Lebanese subsidiary, resulting in lower subsidiaries tax rate. Tax rate is low in domestic business due to certain manufacturing units being eligible for tax exemptions, which led to standalone tax rate of 19% in FY13 (FY12: 20%). These benefits are likely to continue for a couple of years. HIT and Good Knight brands are being amortized over 20 years directly through reserves. Accordingly, INR527.5m (5.9% of FY13 PBT) is being routed through the general reserve every year. Premium on redemption of 0% debentures stood at INR248.2m for FY13 (2.4% of PBT), which has been adjusted directly against the securities premium as permitted by the Companies Act. Also, foreign exchange loss and amalgamation expenses, on amalgamation of Dutch subsidiaries, totaling to ~INR385m (3.8% of FY13 PBT) were adjusted against the reserves instead of routing them through the P/L. ART #2: Key financial insights Employee costs are increasing consistently at the subsidiary level due to acquisitions outside India. Subsidiaries employee costs were 7.7% of consolidated revenue in 1HFY14 (FY13: 6.6%). Bill discounting charges on account of debtors and invoice discounting increased from INR119.8m in FY12 to INR170.6m in FY13 on account of domestic operations. Investors are advised to refer through disclosures made at the end of the Research Report. 21 March 2014 ANNUAL REPORT THREADBARE the ART of annual report analysis Subsidiaries (derived) tax rate reduced from 33% in FY12 to 15% in FY13 pulling down the consolidated tax rate to 17% in FY13 from 23% in FY12 Expenses of INR776m (8.3% of FY13 PBT) routed through the reserves Employee cost at the subsidiary level on the rise Stock Info Bloomberg GCPL IN CMP (INR) 770 Equity Shares (m) M.Cap. (INR b)/(usd b) 262/ Week Range (INR) 977/672 1,6,12 Rel.Perf.(%) -4/-11/-15 Financial summary (INR b) Y/E Mar 2014E 2015E 2016E Sales EBITDA Adj. PAT Adj. EPS (INR) EPS Gr. (%) BV/Sh.(INR) RoE (%) RoCE (%) Payout (%) E: MOSL Estimates Shareholding pattern (%) As on Dec-13 Sep-13 Dec-12 Promoter Domestic Inst Foreign Others ART will present a threadbare portrait of annual reports - statistical, strategic and structured. We believe ART's wide canvas - from accounting and auditing issues to operating performance to management insights to governance matters - will help readers paint a clearer picture of the stock's investment worthiness. Ashish Gupta (Ashish.Gupta@MotilalOswal.com); Chaitanya Arora (Chaitanya.Arora@MotilalOswal.com); Stock performance (1 year) 1

2 ART #1 Consolidated tax rate declined to 17% for FY13 from 23% in FY12 Standalone tax rate stands at 19% in FY13 (FY12: 20%) due to tax exemptions in certain manufacturing units Subsidiaries (derived) tax rate dipped from 33% in FY12 to 15% in FY13 No taxes on royalty income of Indovest Capital, Malaysian subsidiary; rate of royalty increased to 7.9% of Indonesian revenue in FY13 (FY12: 1.8%) ACCOUNTING / AUDITING ISSUES Tax structure in subsidiaries, exemptions in domestic units result in lower tax rate on consolidated basis GCPL has a consolidated tax rate of 17% in FY13 (FY12: 23%), primarily due to exemptions in standalone and lower tax rate in subsidiaries. Standalone tax exemptions Standalone tax rate stood at 19% in FY13 (FY12: 20%) due to certain manufacturing units of the company located in specified areas being eligible for income-tax exemptions. These exemptions are likely to continue for a few more years resulting in lower tax rates at the standalone level (MAT rate as guided by the management). Subsidiaries tax structure Indovest Capital, a subsidiary incorporated in Labuan, Malaysia, had a turnover of INR1.8b with PBT/PAT of INR1.7b in FY13. This has increased from PAT of INR304m in FY12. As explained by management, Indovest Capital owns the trademarks for brands sold in Indonesia, and Indovest s turnover pertains to royalty income from other Indonesian subsidiaries. GCPL s Indonesian subsidiaries are having a tax rate of 30%, while Indovest is a tax-free entity. However, as stated by management, Indonesian subsidiaries are paying a withholding 10% on royalty payment. We also note that rate of royalty as a percentage of aggregate Indonesian subsidiaries turnover increased from 1.8% in FY12 to ~8% in FY13. Since the above royalty transaction is between two subsidiaries, the transaction is eliminated on consolidation. Reporting currency of Indovest Capital is USD. Consolidated tax rate dips from 23% in FY12 to 17% in FY13 due to lower subsidiary taxes Indovest Capital, subsidiary in Labuan, Malaysia royalty transaction structuring Source: Company, MOSL 21 March

3 Royalty income as % of turnover of Indonesian subsidiaries jumped to ~8% in FY13 Tax holidays for African subsidiaries in Nigeria and Mozambique and 0% tax rate for Lebanese subsidiary results in lower tax rate An African subsidiary, Lorna Nigeria had a PBT of INR35m for FY13. The PAT figure, however, was INR200m. As explained by management, subsidiary has received tax refund for previous years resulting in higher PAT. The subsidiary has a pioneer tax status, resulting in 0% corporate income tax for 5 years. Standard corporate tax rate in Nigeria is 30%. Hair Trading (offshore) S. A. L incorporated in Lebanon has profits of ~INR400m in FY13 (FY12: INR11m) with 0% tax. Standard corporate tax rate in Lebanon is 15%. In addition to this, the company also has tax exemptions in the Mozambican subsidiary, Weave Mozambique Limitada. Thus, increase in rate of royalty for Indovest Capital and tax credit in Africa results in tax rate for the subsidiaries coming down from 33% in FY12 to 15% in FY March

4 Lower tax rate for certain subsidiaries result in consolidated tax rate being lower (INR m) Name of subsidiaries FY12 FY13 Turnover PBT PAT Tax Tax Country of Standard corporate tax rates for rate Turnover PBT PAT rate incorporation countries / Remarks (%) (%) PT Intrasari Raya 9, , Indonesia Corporate tax rate is 25% PT Megasari Makmur 7, ,197 1, Indonesia Corporate tax rate is 25% Laboratoria Cuenca 1, , Argentina Corporate tax rate is 35% Keyline Brands Limited (UK) 2, , U.K. Corporate tax rate reduced from 26% in FY12 to 24% in FY13. It will be further reduced to 23% in FY14, 21% in FY15 and 20% thereafter Subinite (Pty) Ltd. 1, , South Africa Corporate tax rate is 28% Hair Trading (offshore) S. A. L , Lebanon Lorna Nigeria 1, , Nigeria Tax Various incentives are granted for eligible investments Company has received tax credit for prior year's tax in FY13. Pioneer tax status, resulting in 0% corporate income tax for 5 years. Standard corporate tax rate is 30%. Cosmetica Nacional , Chile Corporate tax rate is 20% Indovest Capital ,800 1,691 1, Malaysia Profit includes royalty income from other subsidiar(y)/(ies) which gets eliminated on consolidation Weave Mozambique Limitada Godrej South Africa (Pty) (earlier known as Rapidol (Pty)) Style Industries Limited Corporate tax rate is 32%. However, , Mozambique the company operates in a freetrade zone resulting in lower taxes 1, , South Africa Corporate tax rate is 28% , Kenya Corporate tax 30%. For 37.5%. However, there are several exemptions available subject to certain conditions Argencos SA Loss Argentina Corporate tax rate is 35% Godrej Household Products (Bangladesh) Pvt. Ltd Loss Loss Bangladesh Loss-making company, hence no tax Godrej Nigeria Ltd Nigeria Corporate tax rate is 30% Source: Company annual report, KPMG guidance for global corporate tax rates, MOSL Amortisation of INR527.5m (5.9% of FY13 PBT) routed through reserves every year for Good Knight and HIT, due to High court scheme approval Amortization of trademarks/brands over 20 years; HIT and Good Knight amortization routed through general reserve Trademarks and brands for HIT and Good Knight, acquired under a Scheme of Amalgamation with the erstwhile Godrej Household Products Limited (GHPL), are being amortized over a period of 20 years directly through the reserves. Accordingly, GCPL amortizes INR527.5m (5.9% of FY13 PBT) directly through the general reserve every year instead of P&L, based on the High court scheme approval. Further, other trademarks/brands are amortized over a period of ten years through the P&L, except Kinky and Soft & Gentle brand, which are amortized over a period of 20 years. The company added INR861m under trademarks and brands during FY13 which is primarily for the Soft and Gentle brand. 21 March

5 Redemption premium of INR248.2m in FY13 (2.4% of PBT) adjusted directly against reserves Redemption premium on NCDs directly routed through reserves; adjusted PBT higher by 2.4% During FY13, GCPL has issued 2,500 0% redeemable NCDs of INR2.5b with YTM of 9.4%p.a. As permitted under the Companies Act, GCPL amortizes the finance cost directly through the reserves (Securities Premium) instead of P&L. Premium on redemption of debentures stood at INR248.2m in FY13 (FY12: INR272.3m). Had the company accounted for the same through P&L, its profits would have been lower by 2.4% of FY13 PBT (FY12: 2.8%). Premium on redemption of debentures routed through reserves instead of P&L (INR m) Particulars FY11 FY12 FY13 Premium on redemption of debentures Profit before tax 6,529 9,773 10,246 Premium as a % of PBT (%) Forex loss of INR385m (3.8% of FY13 PBT) on merger of Dutch subsidiaries adjusted against reserves Forex differences arising on long-term loans, taken for investment in subsidiaries, amortized over period of loan GCPL operates its ESOP scheme through GCPL ESOP trust which purchases shares from secondary market Forex differences on amalgamation and long term loans capitalised Forex differences on merger: GCPL amalgamated two of its Dutch subsidiaries w.e.f. Sept 30, 2013 and adjusted foreign exchange loss and amalgamation expenses of INR382.8m and INR1.9m respectively directly against reserves. Had these items been routed through P&L, profits would have been lower by ~INR385m (3.8% of FY13 PBT). Forex differences arising on long-term loan: Further, GCPL had earlier exercised the option of amortizing foreign exchange differences arising on long-term foreign currency loan through P&L over the life of the loan (if taken for other than fixed assets) and in the form of depreciation through fixed assets (if taken for fixed assets). The unamortized amount of forex differences was INR112.1m and INR37.4m at the FY12 & FY13 end respectively. This had increased to INR61.1m as at 1HFY14 end. Forex loss in P&L: Loss on foreign currency transactions and translation for FY13 is INR327.8m (FY12: INR205m); 3.2% of FY13 PBT (FY12: 2.1%). Loan to ESOP trust stands at INR503m GCPL operates its ESOP scheme through GCPL ESOP Trust, which is granted a loan by the company to purchase shares from the secondary market. The Trust pays interest on the loan at least at the bank rate. The loan will be repaid by the Trust out of the exercise price received from the employees exercising the options (Exercise price = Market price on date of grant of options + Interest at least at the bank rate). Based on the number of options exercised, the amount recovered from employees will be remitted to the company. However, a SEBI circular has forbidden any further secondary market purchases by ESOP Trusts w.e.f. January 17, All outstanding shares in ESOP Trust (acquired prior to Jan 17, 2013) will have to comply with the SEBI guidelines or be disposed off before June 30, March

6 Loans to GCPL ESOP trust stands at INR503m As explained by the management, the company is in compliance of the SEBI norms currently and no shares need to be disposed off. Loans to ESOP Trust stood at INR503m at the end of FY13 (FY12: INR874.9m). GCPL had altered ESOS scheme during FY13 (GIL shares are allotted in this scheme). No options have been exercised in this scheme till FY m options are outstanding at FY13 end and 1m GIL shares have been sold as the options lapsed Cross-currency movement led to foreign currency translation reserve being negative in FY13 Modification in terms of GIL ESOS scheme; no interest on ESOP price post June 2012 The Employee Stock Option Scheme (ESOS) allowed employees of Godrej Household Products Limited (GHPL) to subscribe to equity shares of Godrej Industries Limited (GIL). The exercise price of each share was equal to market price on date of grant plus interest at a rate not less than bank rate from date of grant till date of exercise. However, during the year, the company modified the terms to charge interest only till 30 th June, m options are outstanding at the end of FY13 (FY11 end: 2.1m options) with exercise period available till December 31, No options have been exercised as at the end of FY13. The company has sold ~1m shares from the ESOP Trust (options forfeited) during FY13 and the Trust has 1.1m shares in the Trust as on Sept 30, m shares pending with the ESOP Trust; no options exercised in the scheme (m) Particulars FY11 FY12 FY13 Options granted Options lapsed/forfeited, pending sale Options lapsed/forfeited and sold Total number of options outstanding Foreign currency translation reserve negative in INR depreciating scenario Foreign currency translation reserve stands at negative INR504.8m in FY13 (FY12: negative INR297.5m), despite INR depreciating by 14% against USD during the year. Ideally, INR depreciation should lead to positive foreign currency translation reserve for positive net worth companies. As explained by the management, there are more than 10 other currencies which are involved due to multi-geographical presence, and the exchange movement of all such currencies resulted in negative foreign currency translation reserve. 21 March

7 ART #2 Bill discounting charges of INR138m in FY13 pertains to domestic business KEY FINANCIAL INSIGHTS Discounting charges on debtors at INR170.6m; majority pertains to domestic business Bill discounting charges increased from INR119.8m in FY12 to INR170.6m in FY13, with a bulk of these expenses forming part of the domestic business. These charges arise on debtors discounting and invoice discounting and form part of the finance cost of the company. As explained by management, the discounting is without recourse. Standalone debtors (net) stood at INR1.2b in FY13 with mere 11 days of receivables. However, the receivable days would be higher if debtors were to be grossed up. Bill discounting charges increased in FY13 (INR m) Particulars FY12 FY13 Standalone Subsidiaries (derived) 0 33 Consolidated Debtors (Standalone) 943 1,221 Employee costs on the rise due to overseas acquisitions Employee costs have jumped from INR4.0b in FY12 to INR5.9b in FY13; 9.1% of FY13 revenue (FY12: 7.6%). For 1HFY14, employee cost stood at INR3.8b (10.3% of 1HFY14 revenue). Employee costs have jumped from INR4.0b in FY12 to INR5.9b in FY13 Employee costs as a percentage of revenue continuously on the rise (INR b) Subsidiary (derived) employee costs were 7.7% of consolidated revenue for 1HFY14 (FY13: 6.6%) leading to rise in overall employee cost Source: Company annual report, Half yearly results, MOSL Further, increase in employee costs is mainly attributable to higher costs at the subsidiary level. Employee costs at the subsidiary level as a percentage of total employee costs increased from 32% in FY09 to 72% in FY13 mainly due to acquisitions made by company outside India. Subsidiary (derived) employee costs were 2% of the consolidated revenues in FY09. This figure has increased to 7.7% during 1HFY March

8 Subsidiaries are the major drivers to increase in employee costs (INR b) Source: Company annual report, Half yearly results, MOSL Indonesian food business under Simba brand sold for a profit INR1.3b Increase in current liabilities due to inorganic additions and working capital optimization across geographies Divestment of non-core business to Creador for USD35m; profit of INR1.3b on the transaction During FY13, the company divested its food business in Indonesia (non-core business) for an enterprise value of USD35m (includes USD6-7m debt) to Creador. This business was operated by an Indonesian subsidiary of the company viz PT Simba Indosnack Makmur. Consequently, PT Simba Indosnack Makmur has ceased to be a subsidiary. Cash received in FY13 was INR880.2m as part consideration, while the balance deferred consideration is shown as a part of other current assets. Disposals in trademarks and brands (intangible assets) stood at INR1.1b, which appear primarily due to sale of the food business. The total profit recorded on divestment of this business is INR1.3b. However, as per the sale agreement, the company will continue the distribution of the Simba brand on a break-even basis for one year which has had an impact on EBITDA margins of the subsidiaries business for 1HFY14. Cash flow from operations supported by current liabilities and provisions Cash flow from operations during FY13 stood lower at INR8.3b (FY12: INR11.0b) aided by current liabilities and provisions of INR4.6b in FY13 (FY12: INR7.0b). Increase in current liabilities and provisions was mainly due to other current payables jumping from INR2.5b in FY12 to INR4.4b in FY13. As per management, the increase is mainly due to inorganic additions and working capital optimization across geographies. Debtors more than six months from due date of payment has jumped from INR58.6m in FY12 to INR329.6m in FY13; 5.5% of FY13 outstanding debtors (FY12: 2.2%). 21 March

9 Working capital supported by increase in current liabilities and provisions Cash flow from operations post interest/ebitda ratio dips sharply (INR m) Particulars FY12 FY13 EBITDA (A) 8,554 9,824 Add: Non-cash adjustments (mainly due to foreign exchange) Less: Direct taxes paid 2,100 2,066 Operating profit before working capital changes 6,742 8,240 Inventories -3,445-2,632 Trade receivables ,177 Loans and advances Other current assets Current liabilities and provisions 7,028 4,550 Cash generated from operations after tax before exceptional items 8,983 7,403 Add: Exceptional items 2, Cash generated from operations 10,985 8,283 Less: Financial cost Cash flow from operations post interest (B) 10,563 7,440 Less: Capital expenditure 1,565 2,636 Less: Investment in subsidiaries 5,791 6,911 Free cash flows post interest 3,207-2,107 Cash flow from operations post interest/ebitda (C = B/A*100) (%) 123% 76% Consolidated cash conversion cycle improves to 35 days in FY13 due to standalone business improving to -14 days while subsidiaries cycle increases to 101 days Cash conversion cycle improves driven by standalone operations; subsidiaries cycle increases marginally Average cash conversion cycle has improved to 35 days in FY13 from 50 days in FY11. The standalone cash conversion cycle has a huge improvement in the number of days from 30 in FY11 to negative 14 in FY13. On the other hand, subsidiary operating cycle is consistently increasing on a yearly basis. From 88 days in FY11, it has now crossed the 100 day mark in FY13. Cash conversion cycle stable due to negative cycle at standalone Particulars FY11 FY12 FY13 Standalone Inventory days Receivable days Payable days Subsidiaries Inventory days Receivable days Payable days Consolidated Inventory days Receivable days Payable days March

10 Bulk of the working capital is being blocked at subsidiary level Other financial highlights Total intangible assets (including goodwill on consolidation) stood at ~INR40b (FY12: INR33b); 1.2x of FY13 net worth (FY12: 1.2x). Debt increased from INR18.8b in FY12 to INR24.6b in FY13 for acquisitions in Africa & Latin America Hedged exposure (USD m) Particulars FY12 FY13 Forward contract Source: Company annual report, MOSL Intangible assets at 1.2x of networth primarily due to goodwill and trademarks (INR b) Particulars FY11 FY12 FY13 Intangible assets - acquired Goodwill on consolidation Total intangible assets Net worth Intangible assets as % of net worth (%) During FY13, the company purchased a capital asset from Godrej Vikhroli Properties LLP (promoter group company) for INR1.0b, which is forming part of CWIP. Debt increased from INR18.8b in FY12 to INR24.6b in FY13 primarily taken for acquisition of Cosmetica Nacional, Chile and Darling group. Debt equity ratio remained stable at 0.7x in FY13. Cash balance of the company has increased significantly from INR6.4b in FY12 to INR8.7b in FY13. Majority of the forex exposure is unhedged at the end of FY13 end (INR m) Nature of outgo Currency FY12 FY13 Payables USD 1,389 3,937 Payables EUR, SGD, JPY, GBP Loan and interest payable USD 2,410 1,345 Bank borrowings USD 47 - Receivables USD ,060 Receivables ZAR, GBP, EUR Cash and cash equivalents USD Cash and cash equivalents EUR, ZAR Net unhedged payables 2,979 3, March

11 ART #3 MANAGEMENT SPEAK/KEY PLANS 3x3 strategy: GCPL has continued to reiterate its commitment to the 3x3 strategy it has in place for a few years now. The 3x3 strategy focuses on 3 core product segments- Hair Care, Home Care and Personal Care and the establishment of the company as the market leader in these segments across 3 continents- Asia, Africa & Latin America. Category-wise sales break-up Household Insecticides Personal Wash Growth of Category (%) Growth of GCPL (%) 27% 26% 20% 10% FY12 FY13 Hair Care Domestic net sales growth 21 March

12 Overseas business increased share to 44% of total revenue in FY13 (FY12: 39%) Geographical sales breakup International markets On the international front, the company is the market leader in air fresheners and wet tissues in Indonesia, hair colors across several countries in Africa and Latin America and hair extensions in Africa, while also being the number two player in home insecticides in Indonesia. The company is pegging its growth on the expansion of the emerging economies like Indonesia in South East Asia and South Africa. In terms of net revenue, the subsidiaries business contributed 44% of the net consolidated revenue of the group in FY13 (39% in FY12). Geographical growth and profitability Subsidiaries revenue increasing consistently as proportion of net revenue Update on acquisitions during the period Darling acquisition steady: GCPL has seen a steady stream of strategic acquisitions in the past few years. The company is still in the process of completing the integration of the Darling Group it has acquired in Africa. The second phase of the incorporation from November, 2012 has extended the reach of the company to the sizable Kenyan market in East Africa. The company hopes to promote new products in the wet hair color market in Kenya under the Darling brand. 21 March

13 Soft & Gentle acquired in UK; 4th largest female deodorant brand in the British market in terms of market share 58% hike in the minimum wages for the Indonesian business and a 33% increase in fuel costs likely to impact EBITDA margins for FY14 Acquisition of Soft & Gentle brand: GCPL has also tried to establish a toe hold in the well-developed UK personal care market on the back of acquisition of Soft & Gentle brand by Keyline Brands, a subsidiary of GCPL, during FY13. Soft & Gentle is the 4th largest female deodorant brand in the British market in terms of market share. Acquired 60% stake in Cosmetica Nacional: The company acquired 60% in Cosmetica Nacional in Chile in FY13 and has launched many new products in the Latin American market through the Ilicit brand. Hair care acquisition: During FY14, the company has acquired a 30% stake in b:blunt, a premium salon chain with 17 outlets and 4 academies across India. The company does not believe the acquisition to be strategically important but is looking at it as a learning investment in terms of hair color and care product preferences among the premium clientele these salons enjoy. Other highlights Production facilities centralized in Mozambique: Production for South Africa and Mozambique has been centralized at the facilities in Mozambique, which are in a declared tax free zone resulting in lower indirect and corporate taxes. Even Nigeria has a 5 year corporate tax holiday thereby reducing the tax incidence in the country. Merger of subsidiaries: During the year, Godrej Nigeria Holdings Ltd merged with Godrej Consumer Products Mauritius Ltd (both wholly owned subsidiaries of GCPL) with effect from April 1, EBITDA margins guidance: During 1HFY14, there has been a 58% hike in the minimum wages for the Indonesian business and a 33% increase in fuel costs. Though there have been price hikes to counter the cost enhancements, its remains to be seen what impact they will have on the overall EBITDA margins of the company. Cross-pollination and its benefits: Due to its expansion and presence in diverse markets across 3 continents, the company is also looking at introducing new products to different sets of consumers by way of cross-pollination. Example: Introduction of Aer range of car and home air fresheners in India, after the product was originally a part of the Indonesian line-up under the Stella brand. Premiumization benefits: The company is also looking at premiumization of its brands to attract a younger, more brand conscious target base. The revamp of Cinthol, with a new brand ambassador and advertising campaign seems to be paying dividends in terms of enhancing the image of the brand and its customer perception. Rural penetration: The company is looking at the potential in the value for money segment which it believes will help in creating rural demand and set the pace of growth in penetration. This has prompted the company to strengthen rural distribution which has resulted in expanding reach by 10% in FY13. ERP system update: The company is deploying SAP in most of the subsidiary units and is currently in the process of integrating them into a single ERP system. 21 March

14 ART #4 Vivek Gambhir appointed as MD after retirement of A. Mahendran in June, 2013 GOVERNANCE MATTERS Composition of Board of Directors and change in management The Board of Directors of GCPL consists of 14 directors, of which 7 are independent directors. Ms. Nisaba Godrej has been appointed as a Whole-time Director designated as Executive Director, Innovation w.e.f 1 st July, 2013 for a period of 3 years. Mr. A Mahendran retired as Managing Director of the company on 30 th June, 2013 and has been appointed as Non-Executive Additional Director w.e.f 1 st July, Mr. Vivek Gambhir, the Chief Strategy Officer of Godrej Industries has been appointed by the company as an Additional Director w.e.f 30 th April, 2013 and is also the Managing Director of the company w.e.f 1 st July, 2013 for a period of 3 years, following the retirement of Mr. A Mahendran. Ms. Ireena Vittal has been appointed as an Additional Director w.e.f 30 th April, Board meetings and attendance 5 Board Meetings were held during the year, as against the minimum requirement of 4 meetings. Attendance of Directors in Board Meetings and AGM Name of the Director Board meetings attended Attendance at last AGM Mr. Adi Godrej 5 Yes Mr. Jamshyd Godrej 5 Yes Mr. Nadir Godrej 4 Yes Ms. Tanya Dubash 4 Yes Ms. Nisaba Godrej 5 Yes Mr. A. Mahendran 5 Yes Mr. Narendra Ambwani 5 Yes Prof. Bala Balachandran 3 (1) Yes Mr. Bharat Doshi 4 (1) Yes Dr. Omkar Goswami 4 Yes Mr. Aman Mehta 4 (1) Yes Mr. D. Shivakumar 3 Yes Note: Figures in brackets indicate attendance through teleconference Outgoing Managing Director A Mahendran receives 1m shares under ESPP Under the Employee Stock Purchase Plan (ESPP), eligible employees of the cadre Vice President and above are to compulsorily subscribe to a maximum of 1m equity shares. The scheme is administered through a Trust set up for this purpose. The company has extended the scheme to Mr. A Mahendran, who was the Managing Director of the company till 30 th June, The shares have been subscribed by Mr. Mahendran at an exercise price equal to market price on the date of grant along with interest till date of exercise. 21 March

15 29,464 shares issued under Employee Stock Grant Scheme in FY13 at exercise price of INR1 (same as face value) Current ESOP scheme with exercise price of INR1 GCPL also has in a place an Employee Stock Grant Scheme. The scheme envisages issue of up to 2.5m equity shares to eligible employees at an exercise price of INR1 each (same as face value of the shares). 29,464 shares have been issued during the year under this scheme. As at the end of FY13, 0.13m grants are outstanding. Transfer of GCPL shares between promoters Promoter shareholding of GCPL stood at 63.3% at the end of 3QFY14. Of this, shareholding of GIL has increased from 21.15% in 1QFY13 to 22.3% (increase by ~115bp) in 3QFY14. The change in shareholding is primarily due to inter-se transfer of promoter stake. GIL has acquired shares from different individual promoters of the company at various prices resulting in total outflow of ~INR3.9b over the last six quarters. Increasing stake of GIL over the period Godrej Consumer Products Limited No. of shares (m) March, 2012 March, 2013 December, 2013 % of Holding No. of shares (m) % of Holding No. of shares (m) % of Holding Holding of GIL Holding of other promoters Total promoter holding Source: BSE, MOSL Amount of money spent by GIL for purchase of stake (INR m) Godrej Industries Ltd. Date 14-Sep Aug Nov Feb-14 Total Price (INR/share) Number of shares purchased (m) Total amount (INR m) 1,102 1, ,868 Source: BSE, MOSL GIL increasing stake in GCPL by purchasing shares from other promoters The company is making the purchases by inter-se transfer of promoter stake and not open market purchase due to: Less liquidity in the stock as they can t get big blocks. Management does not want price to shoot up if they source the same from open market. As per GIL s management, the company is very positive on the prospects of GCPL and hence is keen on buying stake while also being open to increasing stake further. 21 March

16 Financials and Valuation Income Statement (Consolidated) (INR Million) Y/E March E 2015E 2016E Net Sales 48,509 63,908 77,095 90, ,261 Change (%) Cost of Goods Sold 23,185 29,511 36,146 42,157 49,529 Gross Profit 25,324 34,397 40,949 47,989 56,732 Margin (%) Total Expenditure 39,903 53,923 65,756 76,364 89,750 EBITDA 8,607 9,985 11,339 13,782 16,511 Change (%) Margin (%) Depreciation ,022 1,165 Int. and Fin. Charges ,098 1, Other Income-rec ,136 Forex gain/(loss) PBT 7,771 8,957 10,225 12,738 15,565 Change (%) Tax 2,261 1,792 2,156 2,675 3,269 Deferred Tax Tax Rate (%) PAT 5,511 7,165 7,994 9,971 12,187 Change (%) Margin (%) Minority interest Group Adjusted PAT 5,266 6,672 7,342 9,201 11,339 Non-rec. (Exp.)/Income 2,002 1, Reported PAT 7,267 7,961 7,994 9,971 12,187 Balance Sheet (INR Million) Y/E March E 2015E 2016E Share Capital Reserves 27,796 31,564 34,924 40,144 47,502 Minority Int 591 1,170 1,823 2,593 3,440 Net Worth 28,136 31,904 35,264 40,484 47,842 Loans 19,030 13,530 13,731 12,755 11,464 Deferred Liability Capital Employed 47,868 46,784 51,073 56,179 63,203 Gross Block 20,403 25,618 29,843 34,068 38,818 Less: Accum. Depn. 4,940 5,734 6,629 7,651 8,816 Net Fixed Assets 15,464 19,885 23,214 26,417 30,003 Capital WIP Goodwill 21,454 21,454 21,454 21,454 21,454 Currents Assets 22,606 19,096 22,552 26,803 33,082 Inventory 7,839 8,327 9,639 12,349 14,556 Account Receivables 4,725 6,072 7,393 8,644 10,189 Cash and Bank Balance 6, ,080 Loans and Advances 3,143 3,565 4,047 4,595 5,220 Other Current Assets ,037 Curr. Liab. & Prov. 11,815 13,801 16,297 18,646 21,486 Account Payables 7,702 9,866 11,894 13,860 16,279 Other Liabilities 3,684 3,904 4,371 4,745 5,158 Provisions Net Current Assets 10,791 5,296 6,255 8,157 11,596 Net Assets 47,867 46,785 51,073 56,179 63,203 E: MOSL Estimates 21 March

17 Financials and Valuation Ratios Y/E March E 2015E 2016E Basic (INR) EPS Cash EPS BV/Share DPS Payout (%) Valuation (x) P/E Cash P/E EV/Sales EV/EBITDA P/BV Dividend Yield Return Ratios (%) RoE RoCE Working Capital Ratios Debtor (Days) Asset Turnover (x) Leverage Ratio Debt/Equity (x) Cash Flow Statement (INR Million) Y/E March E 2015E 2016E OP/(Loss) before Tax 8,607 9,985 11,339 13,782 16,511 Direct Taxes Paid -2,261-1,792-2,156-2,675-3,269 (Inc)/Dec in WC ,305-1,710 CF from Operations 6,124 7,822 8,445 8,802 11,533 Extraordinary Items 2,002 1, Inc in FA -1,260-5,207-4,225-4,225-4,750 Goodwill -6, CF from Investments -5,309-3,918-4,225-4,225-4,750 Inc in Debt -1,002-5, ,291 Dividend Paid -1,820-3,185-3,982-3,982-3,982 Other Income ,073 1,300 Interest Paid ,098-1, Other Item CF from Fin. Activity -3,252-9,032-4,002-5,084-5,069 Inc/Dec of Cash -2,437-5, ,714 Add: Beginning Balance 2,269 6, Closing Balance 6, ,080 E: MOSL Estimates 21 March

18 Disclosures ART Godrej Consumer Products FY13 This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement Godrej Consumer Products 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly, in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered brokerdealer, MOSIPL, and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. For Singapore Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of Motilal Oswal Capital Markets Singapore Pte Limited: Anosh Koppikar Kadambari Balachandran anosh.koppikar@motilaloswal.com kadambari.balachandran@motilaloswal.com Contact(+65) Contact: (+65) / Office Address:21 (Suite 31),16 Collyer Quay,Singapore Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai March 2014 Phone: reports@motilaloswal.com 18

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 17,602 5,337 Bloomberg GCPL IN Equity Shares (m) 340.3 52-Week Range (INR) 658/370 1,6,12 Rel. Perf. (%) 5/37/42 M.Cap. (INR b) 205.9 M.Cap. (USD b) 3.7 7 August 2012 1QFY13 Results

More information

Hardick Bora

Hardick Bora BSE Sensex S&P CNX 19,990 6,069 Bloomberg JOL IN Equity Shares (m) 159.3 M.Cap. (INR b)/(usd b) 26.0/0.5 52-Week Range (INR) 248/154 1,6,12 Rel. Perf. (%) -18/-28/-34 Financials & Valuation (INR b) Y/E

More information

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat BSE SENSEX S&P CNX 17,384 5,254 Bloomberg JSTL IN Equity Shares (m) 223.1 52-Week Range (INR) 885/464 1,6,12 Rel. Perf. (%) -5/-12/-10 M.Cap. (INR b) 149.5 M.Cap. (USD b) 2.7 Valuation summary (INR b)

More information

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy BSE SENSEX S&P CNX 2,550,318 Bloomberg JPIN IN Equity Shares (m) 1,388.9 M.Cap. (INR b) / (USD b) 51.3/0.9 52-Week Range (INR) 2/1 1,, 12 Rel. Per (%) 1/9/-3 Financials & Valuation (INR m) Y/E Mar 201

More information

Niket Shah

Niket Shah BSE Sensex S&P CNX 20,213 6,147 Bloomberg VGRD IN Equity Shares (m) 29.8 M.Cap. (INR b)/(usd b) 14.6/0.3 52-Week Range (INR) 591/180 1,6,12 Rel. Perf. (%) -8/-6/138 Financial summary (INR b) Y/E March

More information

Urban demand revives; Akzo gaining market share

Urban demand revives; Akzo gaining market share BSE Sensex S&P CNX 22,095 6,601 CMP: INR889 26 March 2014 Update Sector: Consumer Not Rated Urban demand revives; Akzo gaining market share Reiterates focus on Profitable growth Urban demand for Decorative

More information

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 18,755 5,698 Bloomberg GCPL IN Equity Shares (m) 340.3 52-Week Range (INR) 745/370 1,6,12 Rel. Perf. (%) 4/17/67 M.Cap. (INR b) 246.4 M.Cap. (USD b) 4.6 5 November 2012 2QFY13 Results

More information

Sohail Halai Alpesh Mehta

Sohail Halai Alpesh Mehta BSE Sensex S&P CNX 20,039 6,064 Bloomberg IDBI IN Equity Shares (m) 1,278.4 M.Cap. (INR b)/(usd b) 144.9/2.7 52-Week Range (INR) 122/82 1,6,12 Rel.Perf.(%) -1/6/2 Financials & Valuation (INR b) Y/E March

More information

Sanjay Jain Pavas Pethia

Sanjay Jain Pavas Pethia BSE Sensex S&P CNX 19,561 5,923 Bloomberg SAIL IN Equity Shares (m) 4,130.4 M.Cap. (INR b)/(usd b) 334.6/6.2 52-Week Range (INR) 116/76 1,6,12 Rel. Perf. (%) -11/-17/-38 Financials & Valuation (INR b)

More information

CPCB-2: Important long-term driver

CPCB-2: Important long-term driver BSE Sensex S&P CNX 20,860 6,217 19 December 2013 Update Sector: Capital Goods Cummins India CMP: INR461 TP: INR540 Buy Stock Info Bloomberg KKC IN Equity Shares (m) 277.2 52-Week Range (INR) 550/365 1,

More information

Cross service charges at INR m/quarter

Cross service charges at INR m/quarter BSE SENSEX S&P CNX 19,636 5,940 Cummins India CMP: INR504 TP: INR585 Buy LHP products to be an important growth driver Cross service charges at INR100-200m/quarter 20 February 2013 Update Sector: Capital

More information

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Just Dial. CMP: INR1,129 TP: INR1,475 Buy BSE SENSEX S&P CNX 23,871 7,109 Bloomberg JUST IN Equity Shares (m) 70.2 M.Cap. (INR b) / (USD b) 79.2/1.3 52-Week Range (INR) 1,774/589 1, 6, 12 Rel. Per (%) -18/-7/- Financials & Valuation (INR m) Y/E

More information

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy BSE SENSEX S&P CNX 25,665 7,672 Bloomberg AMRJ IN Equity Shares (m) 170.8 M.Cap. (INR b) / (USD b) 88.2/1.4 52-Week Range (INR) 520/208 1, 6, 12 Rel. Per (%) 5/21/97 Financials & Valuation (INR Million)

More information

Pidilite Industries. CMP: INR164 TP: INR186 Buy

Pidilite Industries. CMP: INR164 TP: INR186 Buy BSE SENSEX S&P CNX 16,640 5,043 Bloomberg PIDI IN Equity Shares (m) 506.1 52-Week Range (INR) 188/134 1,6,12 Rel. Perf. (%) 1/20/5 M.Cap. (INR b) 83.0 M.Cap. (USD b) 1.5 27 July 2012 1QFY13 Results Update

More information

Idea Cellular. CMP: INR159 TP: INR200 Buy

Idea Cellular. CMP: INR159 TP: INR200 Buy BSE SENSEX S&P CNX 19,164 5,678 Bloomberg IDEA IN Equity Shares (m) 3,316.2 M.Cap. (INR b) / (USD b) 513.7/8.4 52-Week Range (INR) 176/72 1, 6, 12 Rel. Per (%) 12/45/83 Financials & Valuation (INR Billion)

More information

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key!

CMP: INR320 TP: INR164(-49%) Sell Intending to exit UK execution is key! 31 March 2016 Update Sector: Metals Tata Steel BSE SENSEX S&P CNX 25,342 7,738 Stock Info Bloomberg TATA IN Equity Shares (m) 971.2 52-Week Range (INR) 384/200 1, 6, 12 Rel. Per (%) 18/54/10 M.Cap. (INR

More information

Canara Bank. CMP: INR419 TP: INR525 Buy

Canara Bank. CMP: INR419 TP: INR525 Buy BSE SENSEX S&P CNX 18,817 5,724 Bloomberg CBK IN Equity Shares (m) 443.0 52-Week Range (INR) 566/349 1,6, 12 Rel.Perf.(%) -7/-18/-17 M.Cap. (INR b) 170.3 M.Cap. (USD b) 3.0 7 November 2012 2QFY13 Results

More information

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Shoppers Stop. CMP: INR339 TP: INR355 Neutral BSE SENSEX S&P CNX 20,684 6,145 Bloomberg SHOP IN Equity Shares (m) 83.1 M.Cap. (INR b) / (USD b) 28.1/0.5 52-Week Range (INR) 494/331 1, 6, 12 Rel. Per (%) -7/-16/-28 Financials & Valuation (INR b) Y/E

More information

Godrej Consumer Products

Godrej Consumer Products BSE SENSEX S&P CNX 16,739 5,049 Bloomberg GCPL IN Equity Shares (m) 323.6 52-Week Range (INR) 464/325 1,6,12 Rel. Perf. (%) 3/3/16 M.Cap. (INR b) 135.6 M.Cap. (USD b) 2.7 24 January 2012 3QFY12 Results

More information

To voluntarily stop supplies to US

To voluntarily stop supplies to US BSE Sensex S&P CNX 26,272 7,831 24 July 2014 Update Sector: Healthcare Ipca Laboratories CMP: INR728 TP: INR930 Buy Stock Info Bloomberg IPCA IN Equity Shares (m) 126.2 52-Week Range (INR) 907/609 1, 6,

More information

IndusInd Bank. CMP: INR345 TP: INR419 Buy

IndusInd Bank. CMP: INR345 TP: INR419 Buy BSE SENSEX S&P CNX 17,504 5,332 Bloomberg IIB IN Equity Shares (m) 467.7 52-Week Range (INR) 352/222 1,6,12 Rel.Perf.(%) 13/25/34 M.Cap. (INR b) 161.4 M.Cap. (USD b) 3.1 20 April 2012 4QFY12 Results Update

More information

Punjab National Bank. CMP: INR716 TP: INR950 Buy

Punjab National Bank. CMP: INR716 TP: INR950 Buy BSE SENSEX S&P CNX 16,839 5,100 Bloomberg PNB IN Equity Shares (m) 339.2 52-Week Range (INR) 1,144/703 1,6,12 Rel.Perf.(%) -8/-24/-28 M.Cap. (INR b) 242.8 M.Cap. (USD b) 4.4 30 July 2012 1QFY13 Results

More information

CMP: INR350 TP: INR375 Downgrade to Neutral

CMP: INR350 TP: INR375 Downgrade to Neutral BSE Sensex S&P CNX 19,497 5,897 Bloomberg COAL IN Equity Shares (m) 6,316.4 M.Cap. (INR b)/(usd b) 2,211/41 52-Week Range (INR) 386/301 1,6,12 Rel. Perf. (%) 1/-11/-5 Financials & Valuation (INR b) Y/E

More information

NTPC CMP: INR169 TP: INR191 Buy

NTPC CMP: INR169 TP: INR191 Buy BSE SENSEX S&P CNX 18,625 5,664 Bloomberg NTPC IN Equity Shares (m) 8,245.5 52-Week Range (INR) 190/139 1,6,12 Rel. Perf. (%) 3/-4/-11 M.Cap. (INR b) 1,393.5 M.Cap. (USD b) 26.0 26 October 2012 2QFY13

More information

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral BSE Sensex S&P CNX 19,332 5,855 Bloomberg SANL IN Equity Shares (m) 23.0 M.Cap. (INR b)/(usd b) 53.1/1.0 52-Week Range (INR) 2,450/2,002 1,6,12 Rel. Perf. (%) 9/-1/-4 Financials & Valuation (INR b) Y/E

More information

Market share recovery, price hike, content leverage to drive growth

Market share recovery, price hike, content leverage to drive growth BSE Sensex S&P CNX 24,377 7,276 Stock Info Bloomberg DITV IN Equity Shares (m) 1,064.8 52-Week Range (INR) 71/40 1, 6, 12 Rel. Per (%) 6/-15/-41 M.Cap. (INR b) 58.2 M.Cap. (USD b) 1.0 Financial Snapshot

More information

Siddharth Bothra

Siddharth Bothra BSE Sensex S&P CNX 19,152 5,797 Bloomberg CSTRL IN Equity Shares (m) 494.6 M.Cap. (INR b)/(usd b) 158/2.9 52-Week Range (INR) 338/223 1,6,12 Rel. Perf. (%) 12/-3/26 Financials & Valuation (INR b) Y/E March

More information

Jinesh Gandhi Chirag Jain

Jinesh Gandhi Chirag Jain BSE Sensex S&P CNX 19,561 5,923 Bloomberg EIM IN Equity Shares (m) 27.0 M.Cap. (INR b)/(usd b) 72.0/1.3 52-Week Range 3,240/1,620 1,6,12 Rel. Perf. (%) -4/17/40 Financials & Valuation (INR b) Y/E Dec 2013E

More information

Torrent Pharmaceuticals

Torrent Pharmaceuticals BSE SENSEX S&P CNX 21,338 6,339 Bloomberg TRP IN Equity Shares (m) 169.2 M.Cap. (INR b) / (USD b) 80.4/1.3 52-Week Range (INR) 535/324 1, 6, 12 Rel.Per (%) 4/12/32 Financials & Valuation (INR Million)

More information

CMP: INR826 TP: INR810 (-2%) Neutral

CMP: INR826 TP: INR810 (-2%) Neutral 8 December 2015 Update Sector: Consumer Hindustan Unilever BSE SENSEX S&P CNX 25,310 7,702 CMP: INR826 TP: INR810 (-2%) Neutral Maneuvering pricing in a deflationary environment Delayed winter a risk for

More information

Titan Industries. CMP: INR222 TP: INR220 Neutral

Titan Industries. CMP: INR222 TP: INR220 Neutral BSE SENSEX S&P CNX 17,257 5,241 Bloomberg TTAN IN Equity Shares (m) 887.8 52-Week Range (INR) 255/154 1,6,12 Rel. Perf. (%) -1/13/3 M.Cap. (Rs b) 197.1 M.Cap. (US$ b) 3.6 2 August 2012 1QFY13 Results Update

More information

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral BSE SENSEX S&P CNX 16,846 5,110 Bloomberg SANL IN Equity Shares (m) 23.0 52-Week Range (INR) 2,430/1,980 1,6,12 Rel. Perf. (%) 3/-3/15 M.Cap. (INR b) 50.7 M.Cap. (USD b) 0.9 26 July 2012 2QCY12 Results

More information

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades

CMP: INR124 TP: INR172 Buy. Benefit of two major motorcycle launches not priced in. Improved industry outlook and recent launch success drive upgrades BSE Sensex S&P CNX 24,717 7,359 Stock Info Bloomberg TVSL IN Equity Shares (m) 475.1 52-Week Range (INR) 138/28 1, 6, 12 Rel. Per (%) 34/111/210 M.Cap. (INR b) 59.1 M.Cap. (USD b) 1.0 Financial Snapshot

More information

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral BSE SENSEX S&P CNX 16,846 5,110 Bloomberg JUBI IN Equity Shares (m) 63.5 52-Week Range (INR) 1,189/633 1,6,12 Rel. Perf. (%) 4/38/47 M.Cap. (INR b) 75.5 M.Cap. (USD b) 1.3 26 July 2012 1QFY13 Results Update

More information

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy BSE SENSEX S&P CNX 16,739 5,049 Bloomberg APNT IN Equity Shares (m) 95.9 52-Week Range (INR) 3,366/2,395 1,6,12 Rel. Perf. (%) -5/-3/14 M.Cap. (INR b) 261.1 M.Cap. (USD b) 4.9 23 January 2012 3QFY12 Results

More information

Expect capacity-led rerating; maintain Buy

Expect capacity-led rerating; maintain Buy BSE SENSEX S&P CNX 27,238 8,400 Stock Info Bloomberg SRCM IN Equity Shares (m) 34.8 52-Week Range (INR) 18519/9350 1, 6, 12 Rel. Per (%) -2/-3/32 M.Cap. (INR b) 523.7 M.Cap. (USD b) 7.7 Avg Val, INRm 216.4

More information

BGR Energy. CMP: INR266 TP: INR230 Neutral

BGR Energy. CMP: INR266 TP: INR230 Neutral BSE SENSEX S&P CNX 18,562 5,645 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 374/173 1,6,12 Rel. Perf. (%) -3/27/-24 M.Cap. (INR b) 19.2 M.Cap. (USD b) 0.4 3 November 2012 2QFY13 Results

More information

Financial integrity intact; FDA resolution the key

Financial integrity intact; FDA resolution the key BSE Sensex S&P CNX 25,842 7,843 19 November 2015 Update Sector: Healthcare Dr. Reddy s Lab CMP: INR3,287 TP: INR4,000 (+22%) Buy Stock Info Bloomberg DRRD IN Equity Shares (m) 170.4 M.Cap. (INR b)/(usd

More information

REPORT THREADBARE. New accounting standards from FY The ART of annual report analysis

REPORT THREADBARE. New accounting standards from FY The ART of annual report analysis 23 February 2015 ANNUAL New accounting standards from FY16-17 Financial reporting set for revamp with introduction of Ind-AS The Government has unveiled a roadmap to implement Ind-AS (equivalent IFRS standards)

More information

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy BSE SENSEX S&P CNX 18,210 5,488 28 July 2011 1QFY12 Results Update Sector: Banking Punjab National Bank CMP:INR1,103 TP:INR1,500 Buy Bloomberg PNB IN Equity Shares (m) 316.8 52-Week Range (INR) 1,395/971

More information

Coal India CMP: INR348 TP: INR408 Buy

Coal India CMP: INR348 TP: INR408 Buy BSE SENSEX S&P CNX 17,633 5,348 Bloomberg COAL IN Equity Shares (m) 6,316.4 52-Week Range (INR) 404/294 1,6,12 Rel. Perf. (%) -4/4/-15 M.Cap. (INR b) 2,198.1 M.Cap. (USD b) 39.7 14 August 2012 1QFY13 Results

More information

Idea Cellular. CMP: INR81 TP: INR Under Review

Idea Cellular. CMP: INR81 TP: INR Under Review BSE SENSEX S&P CNX 16,918 5,128 Bloomberg IDEA IN Equity Shares (m) 3,308.8 52-Week Range (INR) 104/71 1,6,12 Rel. Perf. (%) 6/-13/4 M.Cap. (INR b) 268.0 M.Cap. (USD b) 4.8 25 July 2012 1QFY13 Results

More information

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy BSE Sensex S&P CNX 19,608 5,933 Bloomberg UT IN Equity Shares (m) 2,438.8 M.Cap. (INR b)/(usd b) 70/1.3 52-Week Range (INR) 41/18 1,6,12 Rel. Perf. (%) -27/24/-13 Financials & Valuation (INR b) Y/E March

More information

IDBI Bank. CMP: INR106 TP: INR121 Neutral

IDBI Bank. CMP: INR106 TP: INR121 Neutral BSE SENSEX S&P CNX 17,207 5,223 Bloomberg IDBI IN Equity Shares (m) 1,278.4 52-Week Range (INR) 154/77 1,6,12 Rel.Perf.(%) -1/0/-7 M.Cap. (INR b) 135.5 M.Cap. (USD b) 2.6 24 April 2012 4QFY12 Results Update

More information

Reliance Infrastructure CMP: INR528

Reliance Infrastructure CMP: INR528 BSE SENSEX S&P CNX 17,657 5,363 16 August 2012 1QFY13 Results Update Sector: Utilities Reliance Infrastructure CMP: INR528 Buy Bloomberg RELI IN Equity Shares (m) 267.5 52-Week Range (INR) 680/328 1,6,12

More information

Stress test: Weak capital servicing ratios to drive pricing discipline

Stress test: Weak capital servicing ratios to drive pricing discipline Stress test: Weak capital servicing ratios to drive pricing discipline Operating performance near trough; expect gradual improvement 20 Update Cement Our analysis of a cross-section of cement companies

More information

Canara Bank. CMP: INR464 TP: INR645 Buy

Canara Bank. CMP: INR464 TP: INR645 Buy BSE SENSEX S&P CNX 17,234 5,205 Bloomberg CBK IN Equity Shares (m) 443.0 52-Week Range (INR) 672/349 1,6, 12 Rel.Perf.(%) 22/2/-13 M.Cap. (INR b) 205.6 M.Cap. (USD b) 4.1 31 January 2012 3QFY12 Results

More information

BGR Energy. CMP: INR282 TP: INR253 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral BSE SENSEX S&P CNX 17,413 5,283 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 378/173 1,6,12 Rel. Perf. (%) -9/17/-22 M.Cap. (INR b) 20.3 M.Cap. (USD b) 0.4 6 August 2012 1QFY13 Results

More information

Jinesh Gandhi Sandipan Pal

Jinesh Gandhi Sandipan Pal BSE Sensex S&P CNX 20,224 6,157 Bloomberg BCORP IN Equity Shares (m) 77.0 M.Cap. (INR b)/(usd b) 20.5/0.4 52-Week Range (INR) 342/202 1,6,12 Rel. Perf. (%) 6/-15/-23 Financials & Valuation (INR b) Y/E

More information

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive

CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive BSE SENSEX S&P CNX 24,646 7,485 4 March 2016 Update Sector: Capital Goods Siemens CMP: INR1,044 TP: INR970 (-7%) Neutral Sale of Healthcare business margin accretive Stock Info Bloomberg SIEM IN Equity

More information

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy BSE SENSEX S&P CNX 16,216 4,908 Bloomberg LT IN Equity Shares (m) 608.9 52-Week Range (INR) 1,868/971 1,6,12 Rel. Perf. (%) -4/-7/12 M.Cap. (INR b) 706.3 M.Cap. (USD b) 13.1 * Consolidated; EPS is fully

More information

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy BSE SENSEX S&P CNX 16,219 4,924 1 June 2012 6QSY12 Results Update Sector: Sugar CMP: INR26 TP: INR45 Buy Bloomberg SHRS IN Equity Shares (m) 671.0 52-Week Range (INR) 76/23 1,6,12 Rel. Perf. (%) -10/-16/-45

More information

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy BSE Sensex S&P CNX 19,772 5,995 Bloomberg DRRD IN Equity Shares (m) 169.2 M.Cap. (INR b)/(usd b) 344/6.3 52-Week Range (INR) 2,151/1,528 1,6,12 Rel. Perf. (%) -2/9/0 Financials & Valuation (INR b) Y/E

More information

Unitech. CMP: INR20 TP: INR30 Buy

Unitech. CMP: INR20 TP: INR30 Buy BSE SENSEX S&P CNX 16,328 4,943 Bloomberg UT IN Equity Shares (m) 2,438.8 52-Week Range (INR) 38/17 1,6,12 Rel. Perf. (%) -25/-14/-34 M.Cap. (INR b) 48.8 M.Cap. (USD b) 0.9 16 May 2012 4QFY12 Results Update

More information

CMP: INR121 TP: INR193 Buy

CMP: INR121 TP: INR193 Buy BSE SENSEX S&P CNX 17,085 5,139 20 October 2011 2QFY12 Results Update Sector: Metals Hindustan Zinc CMP: INR121 TP: INR193 Buy Bloomberg HZ IN Equity Shares (m) 4,225.3 52-Week Range (INR) 155/109 1,6,12

More information

PVR Ltd. CMP: INR685 TP: INR750 Buy

PVR Ltd. CMP: INR685 TP: INR750 Buy BSE SENSEX S&P CNX 27,860 8,324 Bloomberg PVRL IN Equity Shares (m) 41.3 M.Cap. (INR b) / (USD b) 28.3/0.5 52-Week Range (INR) 747/465 1, 6, 12 Rel. Per (%) -6/9/-19 Financials & Valuation (INR Million)

More information

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Godrej Properties. CMP: INR368 TP: INR420 Neutral BSE SENSEX S&P CNX 21,034 6,252 Bloomberg GPL IN Equity Shares (m) 99.6 M.Cap. (INR b) / (USD b) 36.4/ 0.7 52-Week Range (INR) 641/340 1, 6, 12 Rel. Per (%) -1/-44/-47 Financials & Valuation (INR b) Y/E

More information

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India

CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India BSE SENSEX S&P CNX 27,459 8,497 CMP: INR2,013 TP: INR2,384 (+18%) DBEL to be merged with OCL India 7 November 2016 Update Sector: Cement Dalmia Bharat Buy Stock Info Bloomberg DBEL IN Equity Shares (m)

More information

Godrej Consumer Products

Godrej Consumer Products 3QFY11 Results Update SECTOR: FMCG BSE SENSEX S&P CNX 19,151 5,743 Rs400 Godrej Consumer Products Neutral Bloomberg GCPL IN Equity Shares (m) 323.6 52-Week Range (Rs) 480/225 1,6,12 Rel. Perf. (%) 7/6/46

More information

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block

CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block BSE SENSEX S&P CNX 25,653 7,861 16 May 2016 Update Sector: Fertilizers PI Industries CMP: INR615 TP: INR755(+23%) Buy Nominee Gold has some new competition on the block We recently interacted with the

More information

Jinesh Gandhi Chirag Jain

Jinesh Gandhi Chirag Jain BSE Sensex S&P CNX 19,722 5,995 Bloomberg EIM IN Equity Shares (m) 27.0 M.Cap. (INR b)/(usd b) 88.1/1.6 52-Week Range (INR) 3,285/1,620 1,6,12 Rel. Perf. (%) 10/20/36 Financials & Valuation (INR b) Y/E

More information

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral BSE SENSEX S&P CNX 18,759 5,705 Bloomberg KMB IN Equity Shares (m) 740.7 52-Week Range (INR) 652/418 1,6,12 Rel.Perf.(%) -3/-2/18 M.Cap. (INR b) 463.4 M.Cap. (USD b) 8.6 26 October 2012 2QFY13 Results

More information

BGR Energy. CMP: INR284 TP: INR296 Neutral

BGR Energy. CMP: INR284 TP: INR296 Neutral BSE SENSEX S&P CNX 16,312 4,951 Bloomberg BGRL IN Equity Shares (m) 72.0 52-Week Range (INR) 512/173 1,6,12 Rel. Perf. (%) -8/8/-31 M.Cap. (INR b) 20.5 M.Cap. (USD b) 0.4 31 May 2012 4QFY12 Results Update

More information

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral BSE SENSEX S&P CNX 16,739 5,049 Bloomberg KMB IN Equity Shares (m) 689.3 52-Week Range 515/333 1,6,12 Rel.Perf.(%) 0/12/31 M.Cap. (Rs b) 340.5 M.Cap. (US$ b) 6.7 25 January 2012 3QFY12 Results Update Sector:

More information

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy BSE Sensex S&P CNX 19,990 6,069 Bloomberg LPC IN Equity Shares (m) 447.6 M.Cap. (INR b)/(usd b) 324.5/6.0 52-Week Range (INR) 739/507 1,6,12 Rel. Perf. (%) 9/18/13 Financials & Valuation (INR b) Y/E March

More information

Hindalco. CMP: INR113 TP: INR151 Buy

Hindalco. CMP: INR113 TP: INR151 Buy BSE SENSEX S&P CNX 18,817 5,724 Bloomberg HNDL IN Equity Shares (m) 1,990.0 52-Week Range (INR) 165/100 1,6,12 Rel. Perf. (%) -9/-18/-26 M.Cap. (INR b) 224.9 M.Cap. (USD b) 4.1 Consolidated 2QFY13 Results

More information

CMP: INR859 TP: INR810 (-6%) Neutral

CMP: INR859 TP: INR810 (-6%) Neutral 18 December 2015 Update Sector: Consumer Hindustan Unilever BSE SENSEX S&P CNX 25,519 7,762 CMP: INR859 TP: INR810 (-6%) Neutral Foray into Premium Ayurvedic Hair Oil First Acquisition in a decade Stock

More information

CMP: INR2,623 TP: INR2,875 (+10%) Neutral

CMP: INR2,623 TP: INR2,875 (+10%) Neutral 21 March 2017 Update Sector: Healthcare Dr Reddy s Labs BSE SENSEX S&P CNX 29,485 9,122 Bloomberg DRRD IN Equity Shares (m) 170.4 M.Cap.(INR b)/(usd b) 447.0 / 6.6 52-Week Range (INR) 3689 / 2602 1, 6,

More information

Dabur India. CMP: INR130 TP: INR135 Neutral

Dabur India. CMP: INR130 TP: INR135 Neutral BSE SENSEX S&P CNX 18,625 5,664 29 October 2012 2QFY13 Results Update Sector: Consumer Dabur India CMP: INR130 TP: INR135 Neutral Bloomberg DABUR IN Equity Shares (m) 1,740.7 52-Week Range (Rs) 139/92

More information

Bata India. CMP: INR415 TP: INR483 (+16%) Upgrade to Buy Aggressive, focused strategy to drive growth. Upgrading to Buy

Bata India. CMP: INR415 TP: INR483 (+16%) Upgrade to Buy Aggressive, focused strategy to drive growth. Upgrading to Buy BSE SENSEX S&P CNX 26,393 8,143 Stock Info Bloomberg BATA IN Equity Shares (m) 128.5 52-Week Range (INR) 614 / 400 1, 6, 12 Rel. Per (%) -6/-24/-17 M.Cap. (INR b) 53.3 M.Cap. (USD b) 0.8 Avg Val, INRm

More information

M&M Financial Services

M&M Financial Services BSE SENSEX S&P CNX 18,793 5,717 Bloomberg MMFS IN Equity Shares (m) 102.7 52-Week Range (INR) 938/590 1,6,12 Rel.Perf.(%) 7/24/30 M.Cap. (INR b) 90.7 M.Cap. (USD b) 1.7 23 October 2012 2QFY13 Results Update

More information

Strides Arcolab. CMP: INR717 TP: INR829 Buy

Strides Arcolab. CMP: INR717 TP: INR829 Buy BSE SENSEX S&P CNX 17,144 5,200 Bloomberg STR IN Equity Shares (m) 57.7 52-Week Range (INR) 794/276 1,6,12 Rel. Perf. (%) -2/37/98 M.Cap. (INR b) 41.4 M.Cap. (USD b) 0.7 31 July 2012 2QCY12 Results Update

More information

Gautam Duggad Sreekanth P V S

Gautam Duggad Sreekanth P V S BSE Sensex S&P CNX 19,990 6,069 Bloomberg FRL IN Equity Shares (m) 217.1 M.Cap. (INR b)/(usd b) 33.4/0.6 52-Week Range (INR) 276/127 1,6,12 Rel. Perf. (%) -10/-32/-20 Financials & Valuation (INR b) Y/E

More information

Godawari Power & Ispat

Godawari Power & Ispat BSE SENSEX S&P CNX CMP: INR103 TP: INR185 Buy 17,077 5,158 Bloomberg GODPI IN Equity Shares (m) 31.8 52-Week Range (INR) 200/70 1,6,12 Rel. Perf. (%) 32/-31/-33 M.Cap. (INR b) 3.3 M.Cap. (USD m) 65.3 Consolidated

More information

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy BSE SENSEX S&P CNX 18,714 5,687 Bloomberg AXSB IN Equity Shares (m) 413.2 52-Week Range (INR) 1,309/785 1,6,12 Rel.Perf.(%) 9/-16/-8 M.Cap. (INR b) 462.4 M.Cap. (USD b) 8.7 16 October 2012 2QFY13 Results

More information

Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios

Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios 8 October 2015 Sector Update Financials Individual Housing Loans: Rationalization of Risk-Weights and LTV Ratios Significant capital release for HFCs; Limited benefits for banks Event: RBI reduces risk

More information

CMP: INR475 TP: INR609 (+28%) Buy

CMP: INR475 TP: INR609 (+28%) Buy 10 April 2017 Update Sector: Automobiles Tata Motors BSE SENSEX S&P CNX 29,576 9,181 Stock Info Bloomberg TTMT IN Equity Shares (m) 3,395.9 52-Week Range (INR) 599 / 373 1, 6, 12 Rel. Per (%) -1/-21/8

More information

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Punjab National Bank. CMP: INR768 TP: INR963 Buy BSE SENSEX S&P CNX 16,480 4,975 Bloomberg PNB IN Equity Shares (m) 339.2 52-Week Range (INR) 1,200/751 1,6,12 Rel.Perf.(%) -12/-16/-18 M.Cap. (INR b) 260.5 M.Cap. (USD b) 4.8 10 May 2012 4QFY12 Results

More information

Petronet LNG. CMP: INR146 TP: INR205 Buy

Petronet LNG. CMP: INR146 TP: INR205 Buy BSE SENSEX S&P CNX 17,236 5,229 Bloomberg PLNG IN Equity Shares (m) 750.0 52-Week Range (INR) 186/122 1,6,12 Rel. Perf. (%) 3/-11/-10 M.Cap. (INR b) 109.7 M.Cap. (USD b) 2.0 1 August 2012 1QFY13 Results

More information

Alpesh Mehta Sohail Halai

Alpesh Mehta Sohail Halai BSE Sensex S&P CNX 19,664 5,969 Bloomberg IIB IN Equity Shares (m) 521.8 M. Cap. (INR b)/(usd b) 227/4.1 52-Week Range (INR) 441/242 1,6,12 Rel.Perf.(%) 3/15/52 Financials & Valuation (INR b) Y/E March

More information

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy BSE SENSEX S&P CNX 16,739 5,049 Bloomberg AXSB IN Equity Shares (m) 410.5 52-Week Range 1,461/785 1,6,12 Rel.Perf.(%) 11/-9/-9 M.Cap. (INR b) 413.8 M.Cap. (USD b) 8.2 20 January 2012 Results Update Sector:

More information

Jindal Steel & Power. CMP: INR274 TP: INR379 Buy

Jindal Steel & Power. CMP: INR274 TP: INR379 Buy BSE SENSEX S&P CNX 25,665 7,672 Bloomberg JSP IN Equity Shares (m) 914.9 M.Cap. (INR b) / (USD b) 250.9/4.1 52-Week Range (INR) 350/190 1, 6, 12 Rel. Per (%) -15/-14/3 Financials & Valuation (INR Billion)

More information

CMP: INR415 TP: INR 471 BUY

CMP: INR415 TP: INR 471 BUY 04 Mar 2013 Update Sector: Technology Wipro CMP: INR415 TP: INR 471 BUY Pipeline and deal signings suggest improvement in growth; Multiple levers and focus on productivity will cushion margin headwinds

More information

Eicher Motors. CMP: INR9,281 TP: INR11,401 Buy

Eicher Motors. CMP: INR9,281 TP: INR11,401 Buy BSE SENSEX S&P CNX 25,881 7,727 Bloomberg EIM IN Equity Shares (m) 27.1 M.Cap. (INR b) / (USD b) 251.5/4.1 52-Week Range (INR) 9,350/2,975 1, 6, 12 Rel. Per (%) 9/83/144 Financials & Valuation (INR Million)

More information

Britannia Industries. CMP: INR546 TP: INR605 Upgrade to Neutral Volume growth bottoms out; Upgrade to Neutral

Britannia Industries. CMP: INR546 TP: INR605 Upgrade to Neutral Volume growth bottoms out; Upgrade to Neutral BSE SENSEX S&P CNX 19,016 5,783 Bloomberg BRIT IN Equity Shares (m) 119.5 M.Cap. (INR b)/(usd b) 65.2/1.2 52-Week Range (INR) 595/400 1,6,12 Rel. Perf. (%) 3/10/-13 Financials & Valuation (INR b) Y/E March

More information

Jaiprakash Associates

Jaiprakash Associates BSE SENSEX S&P CNX 16,312 4,951 Bloomberg JPA IN Equity Shares (m) 2,126.5 52-Week Range (INR) 89/50 1,6,12 Rel. Perf. (%) -14/-4/-17 M.Cap. (INR b) 127.9 M.Cap. (USD b) 2.3 31 May 2012 4QFY12 Results

More information

Automobiles. HMSI s expansion could result in short-term pressure on HMCL and BJAUT

Automobiles. HMSI s expansion could result in short-term pressure on HMCL and BJAUT Sector Update Automobiles HMSI s expansion could result in short-term pressure on HMCL and BJAUT Valuations reasonable, but demand recovery key for stock performance Honda Motorcycle and Scooter India

More information

Oberoi Realty. CMP: INR240 TP: INR297 Buy

Oberoi Realty. CMP: INR240 TP: INR297 Buy BSE SENSEX S&P CNX 25,642 7,664 Bloomberg OBER IN Equity Shares (m) 328.2 M.Cap. (INR b) / (USD b) 78.8/1.3 52-Week Range (INR) 276/154 1, 6, 12 Rel. Per (%) -8/-7/-6 Financials & Valuation (INR m) Y/E

More information

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy BSE SENSEX S&P CNX 17,194 5,199 Bloomberg PNB IN Equity Shares (m) 316.8 52-Week Range (INR) 1,234/751 1,6,12 Rel.Perf.(%) 9/-10/-9 M.Cap. (INR b) 297.7 M.Cap. (USD b) 6.0 1 February 2012 3QFY12 Results

More information

CMP: INR949 TP: INR1,140 (+20%) Buy

CMP: INR949 TP: INR1,140 (+20%) Buy BSE SENSEX S&P CNX 26,766 8,204 Stock Info Bloomberg PVRL IN Equity Shares (m) 46.7 52-Week Range (INR) 977/617 1, 6, 12 Rel. Per (%) 3/15/47 M.Cap. (INR b)/ (USD b) 44.3/0.7 Avg Val ( INR m) 157 Free

More information

Castrol India. CMP: INR407 TP: INR474 (+16%) Neutral

Castrol India. CMP: INR407 TP: INR474 (+16%) Neutral BSE SENSEX S&P CNX 23,089 7,019 Bloomberg CSTRL IN Equity Shares (m) 494.6 M.Cap. (INR b) / (USD b) 201/2.9 52-Week Range (INR) 518 / 370 1, 6, 12 Rel. Per (%) 3/3/6 Avg Val (INR m) 128 Free float (%)

More information

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy 14 June 2012 Update Raymond CMP: INR385 TP: INR462 Buy Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy We met the management of Raymond (RW IN, Mkt Cap USD0.4b,

More information

Rebalancing growth. CMP: INR524 TP: INR620 Buy. Domestic outlook constrained, but new levers at inflexion point

Rebalancing growth. CMP: INR524 TP: INR620 Buy. Domestic outlook constrained, but new levers at inflexion point BSE Sensex S&P CNX 22,324 6,653 8 May 2014 Update Sector: Capital Goods Cummins India CMP: INR524 TP: INR620 Buy Stock Info Bloomberg KKC IN Equity Shares (m) 277.2 52-Week Range (INR) 613/365 1, 6, 12

More information

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy BSE SENSEX S&P CNX 18,431 5,598 Bloomberg MSIL IN Diluted Equity Shares (m) 302.1 52-Week Range (INR) 1,498/906 1,6,12 Rel.Perf.(%) 5/-5/20 M.Cap. (INR b) 421.3 M.Cap. (USD b) 7.8 31 October 2012 2QFY13

More information

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification

CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification BSE SENSEX S&P CNX 30,435 9,429 18 May 2017 Update Sector: Utilities CMP: INR830 TP: INR1,040(+25%) Buy Driving value through simplification Stock Info Bloomberg IN Equity Shares (m) 133.2 52-Week Range

More information

Dabur India. CMP: INR106 TP: INR94 Neutral

Dabur India. CMP: INR106 TP: INR94 Neutral 28 July 2011 1QFY12 Results Update Sector: FMCG BSE SENSEX S&P CNX 18,210 5,488 Dabur India CMP: INR106 TP: INR94 Neutral Bloomberg DABUR IN Equity Shares (m) 1,740.0 52-Week Range (INR) 122/87 1,6,12

More information

Sylvania sales a positive

Sylvania sales a positive 14 December 2015 Update Sector: Capital Goods Havells India BSE Sensex S&P CNX 25,150 7,650 Stock Info Bloomberg HAVL IN Equity Shares (m) 623.9 M.Cap. (INR b)/(usd b) 189/2.8 52-Week Range (INR) 316/236

More information

Cummins India. CMP: INR430 TP: INR462 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral BSE SENSEX S&P CNX 16,070 4,870 Bloomberg KKC IN Equity Shares (m) 277.2 52-Week Range (INR) 515/322 1,6,12 Rel. Perf. (%) -3/30/-4 M.Cap. (INR b) 119.2 M.Cap. (USD b) 2.2 17 May 2012 4QFY12 Results Update

More information

KPIT Technologies. CMP: INR175 TP: INR170 Downgrade to Neutral

KPIT Technologies. CMP: INR175 TP: INR170 Downgrade to Neutral BSE SENSEX S&P CNX 26,026 7,768 Bloomberg KPIT IN Equity Shares (m) 194.9 M.Cap. (INR b) / (USD b) 34.0/0.6 52-Week Range (INR) 191/122 1, 6, 12 Rel. Per (%) 2/-27/4 Financials & Valuation (INR Billion)

More information

Prestige Estates. CMP: INR169 TP: INR195 Buy FY13 sales booking to beat guidance by ~20%

Prestige Estates. CMP: INR169 TP: INR195 Buy FY13 sales booking to beat guidance by ~20% BSE SENSEX S&P CNX 19,244 5,858 Bloomberg PEPL IN Equity Shares (m) 328.1 52-Week Range (INR) 171/58 1,6,12 Rel. Perf. (%) 0/30/119 M.Cap. (INR b) 55.6 M.Cap. (USD b) 1.0 Valuation summary (INR b) Y/E

More information